Literature DB >> 23182073

Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia.

María Ángeles Clari1, Dayana Bravo, Elisa Costa, Beatriz Muñoz-Cobo, Carlos Solano, María José Remigia, Estela Giménez, Omar J Benmarzouk-Hidalgo, Pilar Pérez-Romero, David Navarro.   

Abstract

CMV DNA loads measured by the new Abbott RealTime CMV PCR were significantly higher than those quantitated by the Abbott CMV PCR kit (approximately 1 log(10)), and provided a better estimate of the actual CMV load present in plasma specimens as inferred by the use of the WHO standard.
Copyright © 2013 Elsevier Inc. All rights reserved.

Mesh：

Substances：

Year:  2012        PMID： 23182073     DOI： 10.1016/j.diagmicrobio.2012.10.010

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  10 in total

1.  Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.

Authors:  C Solano; E Giménez; J L Piñana; V Vinuesa; S Poujois; S Zaragoza; M Calabuig; D Navarro
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

2.  The kinetics of torque teno virus plasma DNA load shortly after engraftment predicts the risk of high-level CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Authors:  E Albert; C Solano; E Giménez; D Focosi; A Pérez; L Macera; J L Piñana; J C H Boluda; F Maggi; D Navarro
Journal:  Bone Marrow Transplant       Date:  2017-10-30       Impact factor: 5.483

3.  When should preemptive antiviral therapy for active CMV infection be withdrawn from allogeneic stem cell transplant recipients?

Authors:  C Solano; E Giménez; J L Piñana; J C Hernández-Boluda; P Amat; V Vinuesa; D Navarro
Journal:  Bone Marrow Transplant       Date:  2017-06-05       Impact factor: 5.483

4.  Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?

Authors:  Estela Giménez; Beatriz Muñoz-Cobo; Carlos Solano; Paula Amat; David Navarro
Journal:  J Clin Microbiol       Date:  2013-11-27       Impact factor: 5.948

5.  An investigation of the utility of plasma Cytomegalovirus (CMV) microRNA detection to predict CMV DNAemia in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Alberto Talaya; Estela Giménez; María Jesús Pascual; Beatriz Gago; José Luis Piñana; Juan Carlos Hernández-Boluda; Lourdes Vázquez; Magdalena García; David Serrano; Marta Hernández; Eliseo Albert; Carlos Solano; David Navarro
Journal:  Med Microbiol Immunol       Date:  2019-09-03       Impact factor: 3.402

6.  Kinetics of inflammatory biomarkers in plasma predict the occurrence and features of cytomegalovirus DNAemia episodes in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Alberto Talaya; Estela Giménez; Víctor Vinuesa; Ariadna Pérez; Paula Amat; José Luis Piñana; Eliseo Albert; Juan Carlos Hernández-Boluda; Carlos Solano; David Navarro
Journal:  Med Microbiol Immunol       Date:  2019-03-25       Impact factor: 3.402

7.  Comparison of Two Commercial Automated Nucleic Acid Extraction and Integrated Quantitation Real-Time PCR Platforms for the Detection of Cytomegalovirus in Plasma.

Authors:  Huey-Pin Tsai; You-Yuan Tsai; I-Ting Lin; Pin-Hwa Kuo; Tsai-Yun Chen; Kung-Chao Chang; Jen-Ren Wang
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

8.  Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia.

Authors:  José Luis Piñana; Estela Giménez; María Dolores Gómez; Ariadna Pérez; Eva María González; Víctor Vinuesa; Juan Carlos Hernández-Boluda; Juan Montoro; Miguel Salavert; Mar Tormo; Paula Amat; Paula Moles; Carlos Carretero; Aitana Balaguer-Roselló; Jaime Sanz; Guillermo Sanz; Carlos Solano; David Navarro
Journal:  J Infect       Date:  2019-02-21       Impact factor: 6.072

9.  Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections.

Authors:  José Luis Piñana; María Dolores Gómez; Ariadna Pérez; Silvia Madrid; Aitana Balaguer-Roselló; Estela Giménez; Juan Montoro; Eva María González; Víctor Vinuesa; Paula Moles; Juan Carlos Hernández-Boluda; Miguel Salavert; Marisa Calabuig; Guillermo Sanz; Carlos Solano; Jaime Sanz; David Navarro
Journal:  Transpl Infect Dis       Date:  2018-06-22       Impact factor: 2.228

10.  Commutability of Cytomegalovirus WHO International Standard in Different Matrices.

Authors:  Sara Jones; Erika M Webb; Catherine P Barry; Won S Choi; Klara B Abravaya; George J Schneider; Shiaolan Y Ho
Journal:  J Clin Microbiol       Date:  2016-03-30       Impact factor: 5.948
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.